Frank Atkins

1.1k total citations
25 papers, 692 citations indexed

About

Frank Atkins is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Frank Atkins has authored 25 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Surgery. Recurrent topics in Frank Atkins's work include Thyroid Cancer Diagnosis and Treatment (16 papers), Radiation Dose and Imaging (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Frank Atkins is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), Radiation Dose and Imaging (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Frank Atkins collaborates with scholars based in United States, Poland and China. Frank Atkins's co-authors include Douglas Van Nostrand, Leonard Wartofsky, Kenneth D. Burman, Elmo Acio, Shari Moreau, Mihriye Mete, Jacqueline Jonklaas, Harvey A. Ziessman, Carlos Alexandre Borges Garcia and Jason G. Umans and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Journal of Nuclear Medicine.

In The Last Decade

Frank Atkins

25 papers receiving 682 citations

Peers

Frank Atkins

EDM

RNMI

SURGE

ONCOL

PRM

Petra Petranović Ovčariček Switzerland

Anna Aronova United States

Didem Özdemir Türkiye

N Molea Italy

U. Tiefenbacher Germany

Kohei Kotani Japan

William H. Lakey Canada

K. L. Parthasarathy United States

Yu Min China

Chul‐min Lee South Korea

Petra Petranović Ovčariček Switzerland

Frank Atkins

317 ×0.7

EDM

120 ×0.4

RNMI

143 ×0.6

SURGE

84 ×0.9

ONCOL

84 ×1.2

PRM

Citations per year, relative to Frank Atkins Frank Atkins (= 1×) peers Petra Petranović Ovčariček

Countries citing papers authored by Frank Atkins

Since Specialization

Citations

This map shows the geographic impact of Frank Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Atkins more than expected).

Fields of papers citing papers by Frank Atkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Atkins. The network helps show where Frank Atkins may publish in the future.

Co-authorship network of co-authors of Frank Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Atkins. A scholar is included among the top collaborators of Frank Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Atkins. Frank Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plyku, Donika, Robert F. Hobbs, Frank Atkins, et al.. (2017). Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in¹²⁴I PET/CT–Based Dosimetry for¹³¹I Therapy of Metastatic Differentiated Thyroid Cancer. Journal of Nuclear Medicine. 58(7). 1146–1154. 40 indexed citations

Atkins, Frank, Douglas Van Nostrand, Shari Moreau, Kenneth D. Burman, & Leonard Wartofsky. (2015). Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of ¹³¹ I. Thyroid. 25(12). 1347–1350. 7 indexed citations

Nostrand, Douglas Van, Shari Moreau, Frank Atkins, et al.. (2012). Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with ¹³¹I Planar Whole-Body Imaging and ¹²⁴I PET. Journal of Nuclear Medicine. 53(3). 359–362. 36 indexed citations

Kłubo-Gwieździńska, Joanna, Douglas Van Nostrand, Frank Atkins, et al.. (2011). Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 96(10). 3217–3225. 75 indexed citations

Nostrand, Douglas Van, et al.. (2010). Radiopharmacokinetics of Radioiodine in the Parotid Glands After the Administration of Lemon Juice. Thyroid. 20(10). 1113–1119. 30 indexed citations

Garcia, Carlos Alexandre Borges, Douglas Van Nostrand, Frank Atkins, et al.. (2010). Effective Reduction of Brown Fat FDG Uptake by Controlling Environmental Temperature Prior to PET Scan: an Expanded Case Series. Molecular Imaging and Biology. 12(6). 652–656. 8 indexed citations

Nostrand, Douglas Van, Shari Moreau, Frank Atkins, et al.. (2010). ¹²⁴ I Positron Emission Tomography Versus ¹³¹ I Planar Imaging in the Identification of Residual Thyroid Tissue and/or Metastasis in Patients Who Have Well-Differentiated Thyroid Cancer. Thyroid. 20(8). 879–883. 56 indexed citations

Nostrand, Douglas Van, Shari Moreau, Frank Atkins, et al.. (2010). Survival rate (SR) in patients (pts) diagnosed (dx’ed) with well-differentiated thyroid cancer (WDTC) with bone metastases (BMs). 51. 1591–1591. 3 indexed citations

Nostrand, Douglas Van, Frank Atkins, Shari Moreau, et al.. (2009). The Utility of Radioiodine Scans Prior to Iodine 131 Ablation in Patients with Well-Differentiated Thyroid Cancer. Thyroid. 19(8). 849–855. 64 indexed citations

10.

Nostrand, Douglas Van, Frank Atkins, Shari Moreau, et al.. (2009). Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma. Thyroid. 19(10). 1093–1098. 25 indexed citations

11.

Nostrand, Douglas Van, et al.. (2009). Salivary Gland Protection with Sialagogues: A Case Study. Thyroid. 19(9). 1005–1008. 24 indexed citations

12.

Nostrand, Douglas Van, et al.. (2008). Utility of PET/Neck MRI Digital Fusion Images in the Management of Recurrent or Persistent Thyroid Cancer. Thyroid. 18(2). 103–111. 24 indexed citations

13.

Burman, Kenneth D., et al.. (2005). Radioiodine Therapy for Thyroid Cancer and Hyperthyroidism in Patients with End-Stage Renal Disease on Hemodialysis. Thyroid. 15(12). 1321–1331. 54 indexed citations

14.

Ziessman, Harvey A., et al.. (2004). Standardization and quantification of radionuclide solid gastric-emptying studies.. PubMed. 45(5). 760–4. 21 indexed citations

15.

Nostrand, Douglas Van, et al.. (2002). Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma. Thyroid. 12(2). 121–134. 106 indexed citations

16.

Peck, Ronald A., Matthew W. Harding, Yow‐Ming Wang, et al.. (2001). Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin. Journal of Clinical Oncology. 19(12). 3130–3141. 82 indexed citations

17.

Rehm, Patrice K., et al.. (1997). Artifact on Bone SPECT of the Lumbar Spine. Clinical Nuclear Medicine. 22(2). 133–134. 1 indexed citations

18.

Rehm, Patrice K., Frank Atkins, & Harvey A. Ziessman. (1996). Positive technetium-99m-red blood cell gastrointestinal bleeding scan after barium small-bowel study.. PubMed. 37(4). 643–5. 1 indexed citations

19.

Gouge, Steven F., et al.. (1991). Radiocontrast Removal by Dialysis Membranes. Blood Purification. 9(4). 182–187. 10 indexed citations

20.

Alijani, M.R., et al.. (1983). Application of the Kidney to Aortic Blood Flow Index to Renal Transplants. Clinical Nuclear Medicine. 8(8). 360–364. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact